Englerin A Stimulates PKC?? to Inhibit Insulin Signaling and to Simultaneously Activate HSF1: Pharmacologically Induced Synthetic Lethality

导出原文传递

翻译打印收藏纠错

作者： Sourbier,C. ^[1] ; Scroggins,B.T. ^[2] ; Ratnayake,R. ^[3] ; Prince,T.L. ^[4] ; Lee,S. ; Lee,M.-J. ; Nagy,P.L. ; Lee,Y.H. ; Trepel,J.B. ; Beutler,J.A. ; Linehan,W.M. ; Neckers,L.

作者单位： Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD ^[1] Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes ^[2] N-Gene Research Laboratories, Inc., 1137 Budapest, Hungary ^[3] Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National ^[4]

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Cancer Cell

2013年23卷2期

228-237页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Englerin A Stimulates PKC?? to Inhibit Insulin Signaling and to Simultaneously Activate HSF1: Pharmacologically Induced Synthetic Lethality

Cancer Cell

相似文献

Cancer Cell

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Englerin A Stimulates PKC?? to Inhibit Insulin Signaling and to Simultaneously Activate HSF1: Pharmacologically Induced Synthetic Lethality

Cancer Cell

相似文献

Cancer Cell

相关期刊

检索历史清除